Ginkgo Bioworks Holdings (DNA) Change in Receivables (2020 - 2026)

Ginkgo Bioworks Holdings (DNA) has reported Change in Receivables for 7 consecutive years, with -$3.7 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Change in Receivables fell 29.6% year-over-year to -$3.7 million; the trailing twelve-month figure through Jun 2026 stood at $200000.0 (down 85.96% YoY), and the FY2025 full-year result was $1.5 million, down 68.83% from the prior year.
• Change in Receivables eased to -$3.7 million in Q2 2026 per DNA's latest filing, from $242000.0 in the prior quarter.
• Across five years, Change in Receivables topped out at $6.8 million in Q1 2024 and bottomed at -$34.5 million in Q4 2022.
• Historically, Change in Receivables has averaged -$5.5 million across 5 years, with a median of -$1.4 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Change in Receivables sank 140.0% in 2022, then surged 1187.07% in 2024.
• Over 5 years, Change in Receivables stood at -$34.5 million in 2022, then rose by 16.24% to -$28.9 million in 2023, then surged by 95.24% to -$1.4 million in 2024, then soared by 232.12% to $1.8 million in 2025, then tumbled by 304.24% to -$3.7 million in 2026.
• According to Business Quant data, Change in Receivables over the past three periods registered -$3.7 million, $242000.0, and $1.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.